Exchange: NASDAQ·Updated 04:00 PM EDT
IMDX logo

IMDX Insight Molecular Diagnostics Inc.

$4.13
$0.16
(3.73%)
Today
Reported EarningsAug 10
Mkt Cap$135.15M
Vol81,035.00

About IMDX

Insight Molecular Diagnostics, Inc. is a diagnostics technology company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO. The company was founded in September 2009 and is headquartered in Nashville, TN.
39

Bearish Sentiment

How do you feel about IMDX?

Advertisement|Remove ads.